1400 studies found for:    alzheimer
Show Display Options
Rank Status Study
41 Completed
Has Results
Clinical Effectiveness of 10 cm^2 Rivastigmine Patch in Patients With Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention: Drug: Rivastigmine 5 and 10 cm^2 patch
42 Recruiting A Randomized, Double-blind, Placebo-controlled Study to Assess Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Pharmacodynamic Response of Repeated Intravenous Infusions of BAN2401 in Subjects With Mild Cognitive Impairment Due to Alzheimer's Disease and Mild Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: BAN2401 2.5 mg /kg;   Drug: BAN2401 5 mg /kg;   Drug: BAN2401 10 mg /kg;   Drug: Placebo
43 Completed Alzheimer's Disease Treatment and Illness Perceptions Survey (TIPS) II
Condition: Alzheimer Disease
Intervention:
44 Completed A Study to Assess Regional Cerebral Blood Flow as an Alzheimer's Disease Biomarker Compared to Positron Emission Tomography in Patients With Mild-to-Moderate Alzheimer's Disease and Cognitively Normal Elderly Subjects (Study MK-0000-068)(COMPLETED)
Condition: Alzheimer's Disease
Interventions: Other: MRI;   Other: FDG-PET
45 Completed Safety and Efficacy Study of Ladostigil in Mild to Moderate Probable Alzheimer's Disease
Conditions: Alzheimer's Disease;   Dementia;   Memory Loss;   Cognitive Impairment
Intervention: Drug: ladostigil hemitartrate
46 Recruiting Safety Study of AADvac1, a Tau Peptide-KLH-Conjugate Active Vaccine to Treat Alzheimer's Disease
Condition: Alzheimer Disease
Intervention: Drug: AADvac1
47 Completed Adding Atomoxetine To Standard Medication Treatment In Patients With Alzheimer's Disease
Condition: Alzheimer Disease
Interventions: Drug: atomoxetine hydrochloride;   Drug: placebo
48 Completed
Has Results
Safety, Tolerability, and Pharmacokinetic Study of EVP-6124 in Patients With Alzheimer's Disease
Conditions: Alzheimer's Disease;   Central Nervous System Diseases
Interventions: Drug: EVP-6124 (0.1 mg/day);   Drug: EVP-6124 (0.3 mg/day);   Drug: EVP-6124 (1.0 mg/day);   Drug: Comparator: Placebo;   Drug: Donepezil;   Drug: Rivastigmine
49 Completed Effect of LY450139 on the Long Term Progression of Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: LY450139;   Drug: placebo
50 Not yet recruiting 18-months Safety Follow-up Study of AADvac1, an Active Tau Vaccine for Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention: Drug: AADvac1
51 Completed Ecological Assessment of Apathy in Alzheimer's Disease and in Control Subjects: Video Recognition and Actigraphy
Condition: Alzheimer Disease
Intervention: Other: observational
52 Completed European Study of HF0220 in Mild to Moderate Alzheimer's Disease Patients
Condition: Alzheimer's Disease
Intervention: Drug: HF0220
53 Completed Blood Gene Expression Signature in Patients Diagnosed With Probable Alzheimer's Disease Compared to Patients Suffering From Other Types of Dementia
Conditions: Alzheimer's Disease;   Dementia
Intervention: Device: Blood sampling
54 Completed Randomized Trial of a Nutritional Supplement in Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Dietary Supplement: Resveratrol with Glucose, and Malate;   Dietary Supplement: Placebo
55 Recruiting Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Condition: Alzheimer's Disease
Interventions: Drug: Solanezumab;   Drug: Placebo
56 Recruiting Sleep Apnea in Early to Mid-Stage Alzheimer's Disease
Conditions: Early Onset Alzheimer Disease;   Alzheimer Disease;   Obstructive Sleep Apnea Syndromes
Interventions: Device: CPAP Treatment;   Device: No treatment
57 Completed
Has Results
Safety of Switching From Donepezil to Rivastigmine Patch in Patients With Probable Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Rivastigmine 5 cm^2 transdermal patch;   Drug: Rivastigmine 10 cm^2 transdermal patch
58 Not yet recruiting Evaluation of the Efficacy and Safety of TTP488 in Patients With Mild Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: TTP488;   Drug: Placebo
59 Completed Influence of Age on Amyloid Load in Alzheimer's Disease and in Atypical Focal Cortical Alzheimer's Disease
Conditions: Alzheimer's Disease;   Posterior Cortical Atrophy;   Logopenic Progressive Aphasia
Intervention:
60 Unknown  Contribution of Actigraphy and Recognition Video in Apathy Assessment of Alzheimer's Disease : Experimental Research
Condition: Alzheimer's Disease
Intervention: Other: Actigraphy and video recording signal

Indicates status has not been verified in more than two years